Flora Growth Corp. Announces Pricing of $2.7 Million Registered Direct Offering and Concurrent Private PlacementNewsfile Corp • 09/19/23
Flora Growth Corp. to Acquire Australian Vaporizers; Expects Immediate Profit ContributionNewsfile Corp • 09/18/23
Flora Growth Corp. and TruHC Pharma GmbH Establish Strategic Partnership to Grow Market Share in GermanyNewsfile Corp • 08/17/23
Flora Growth Corp. Announces Update on Sale of Colombian Assets; Expects Asset Sale to Contribute to Anticipated Annual Savings of US$6.1 millionNewsfile Corp • 07/25/23
Flora Growth Corp. Appoints Clifford Starke as Chief Executive Officer and Dany Vaiman as Chief Financial Officer; Regains Compliance with NASDAQ Minimum Bid RequirementNewsfile Corp • 06/27/23
Flora Growth Corp. Announces Change to Location of Annual and Special MeetingBusiness Wire • 05/24/23
Flora Growth Corp. Announces the Appointment of Hussein Rakine as CEO and Member of the Board of DirectorsBusiness Wire • 04/18/23
Flora Growth Receives CGMP Certification of Compound Formulation Lab; Launches Prescription Cannabis Medicines in ColombiaBusiness Wire • 04/04/23
Flora Growth Reports 2022 Year-End Financial Results: $37.2M in Revenue, 314% Growth Year-Over-YearBusiness Wire • 03/31/23
Flora Growth to Announce 2022 Year End Results April 3, 2023, at 8:00 a.m. ETBusiness Wire • 03/21/23
Flora Growth Begins Product Sales in Juan Valdez, Colombia's Largest Coffeehouse ChainBusiness Wire • 02/21/23
Flora Growth Issues 2023 Revenue Guidance of $90 Million to $105 Million Reflecting Anticipated Year Over Year Growth Exceeding 100%Business Wire • 01/30/23
Flora Growth Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price RuleBusiness Wire • 01/06/23
Flora Growth Provides Update to International Commercial Cannabis Export BusinessBusiness Wire • 01/05/23